医学
随机对照试验
多中心试验
脚手架
多中心研究
外科
粘附
化学
生物医学工程
有机化学
作者
Huiyan Wang,Xiaoyan Gu,Taishun Li,Xiaoyu Niu,Hong Zhang,Qing Yang,Yuanjing Hu,Feng Xu,Biyun Xu,Hui Zhu,Zhipeng Tian,Meining Song,Yali Hu
标识
DOI:10.1016/j.fertnstert.2025.08.035
摘要
OBJECTIVE: To evaluate the efficacy of collagen scaffold vs. intrauterine device (IUD) in the prevention of adhesion recurrence in moderate intrauterine adhesions (IUA) after hysteroscopic adhesiolysis. DESIGN: A multicenter, open-label, randomized controlled, two-arm superiority clinical trial. SUBJECTS: Participants aged 20-40 years with moderate IUAs (based on American Fertility Society [AFS] score 5-8) planned to accept hysteroscopic adhesiolysis. INTERVENTION: Participants were randomly allocated to a collagen scaffold group or IUD group (1:1) and received hormonal therapy after surgery. A second-look hysteroscopy (SLH) was scheduled at 2 months after the adhesiolysis. MAIN OUTCOME MEASURES: The primary outcome was the rate of no IUA recurrence at SLH. The secondary outcomes included AFS score at SLH, decrease of AFS score at SLH, and menstrual pattern improvement at 1-month and 2-month postoperation. RESULTS: A total of 195 patients were randomized to the collagen scaffold group (n = 98) or IUD group (n = 97). The rate of no IUA recurrence at SLH in the collagen scaffold group was significantly higher than that in IUD group (78.6% vs. 58.8%; relative risk, 1.4; 95% confidence interval, 1.1-1.6). There was no significant difference in the AFS score and a decrease in AFS score at SLH between the two groups. The incidence of adverse events did not differ between the two groups and no serious adverse events were reported. CONCLUSION: Collagen scaffold is superior to IUD in preventing adhesion recurrence after hysteroscopic adhesiolysis in moderate IUAs. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR2300068271.
科研通智能强力驱动
Strongly Powered by AbleSci AI